Main > RHEUMATOLOGY > Axial SpondyloArthritis > Treatment > Co: USA. B. BioSimilar AdalimuMAb

---

Co: USA. B. BioSimilar AdalimuMAb's subsections
(*) EU Approval Date: 2017. 08.24
Company
Developed By:
TradeMark

Co: USA. B. BioSimilar AdalimuMAb's products
This section has no products